AstraZeneca Plc (AZN):企業のM&A・提携動向(医療機器分野)

◆英語タイトル:AstraZeneca Plc (AZN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME3904D
◆発行会社(調査会社):GlobalData
◆発行日:2017年2月14日
◆ページ数:117
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:英国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory, inflammation, autoimmune disease (RIA); cardiovascular and metabolic disease (CVMD); and cancer, besides infection and neurological diseases. The company’s product portfolio includes biologics, prescription pharmaceuticals and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies and through distributors and local representative offices. The company markets its products to primary care and specialty care physicians. The company operates in Europe, the Americas, Asia, Africa and Australasia. AstraZeneca is headquartered in London, the UK.

AstraZeneca Plc (AZN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
AstraZeneca Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
AstraZeneca Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 8
AstraZeneca Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
AstraZeneca Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 10
AstraZeneca Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
AstraZeneca Plc, Medical Equipment, Deal Details 14
Venture Financing 14
Definiens Raises USD20.3 Million in Venture Financing Round 14
CeraPedics Raises US$19 Million In Series C Financing 15
Definiens Raises US$13 Million In Venture Financing 16
Ambit Biosciences Secures US$30 Million In Series D-2 Financing 17
Partnerships 19
AstraZeneca Enters into Agreement with Genedata 19
Neoprobe Enters Into Licensing Agreement With AstraZeneca 20
AgPlus Diagnostics Enters into Agreement with AstraZeneca 21
Indivumed Partners with Definiens 22
Foundation Medicine Enters into Agreement with AstraZeneca 23
MedImmune Enters into Agreement with Genisphere 23
Definiens Partners with MolecularMD 24
Human Longevity Partners with AstraZeneca 25
PROOF Centre Partners with AstraZeneca 26
Labcyte Enters into Agreement with AstraZeneca 26
HighRes Biosolutions Enters into Agreement with AstraZeneca 27
AstraZeneca Enters into Research Agreement with Sutter Health 28
Myriad Genetics Expands Agreement with AstraZeneca 29
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 30
AstraZeneca Enters into Co-Development Agreement with Qiagen 31
AstraZeneca Enters into Co-Development Agreement with Roche 32
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 32
Ventana Medical Enters into Co-Development Agreement with MedImmune 33
Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test 34
Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 35
Oxford Cancer Biomarkers Enters Into Agreement With AstraZeneca For Biomarker Discovery 36
AstraZeneca Enters Into Research Agreement With Karolinska Institutet 36
Metamark Genetics Enters Into Co-Development Agreement With Definiens 37
Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement 38
Leica Microsystems Enters Into Co-Marketing Agreement With Definiens 39
Definiens Enters Into An Agreement With Cernostics 40
Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens 41
Merger 42
AstraZeneca Rumored To Merge With Amgen 42
Debt Offering 43
AstraZeneca Prices Private Placement of 0.875% Notes Due 2021 43
Acquisition 43
Pfizer May Increase Bid to Acquire AstraZeneca 43
MedImmune Acquires Definiens for USD150 Million 45
AstraZeneca Rumored To Acquire Forest Labs For US$15 Billion 46
Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company 47
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 48
DENTSPLY International Acquires Astra Tech From AstraZeneca For US$1,800 Million 49
AstraZeneca Plc – Key Competitors 52
Key Employees 53
Locations And Subsidiaries 55
Head Office 55
Other Locations & Subsidiaries 55
Recent Developments 61
Strategy And Business Planning 61
Apr 04, 2016: Heptares Joins Pharma Consortium Applying State of the Art Cryo-Electron Microscopy to Advance Structure Based Drug Discovery 61
Financial Announcements 62
Feb 02, 2017: Astrazeneca Announces Full-Year and Q4 2016 Results 62
Nov 10, 2016: AstraZeneca: Year-To-Date and Q3 2016 Results 63
Jul 28, 2016: AstraZeneca: H1 2016 Results 75
Apr 29, 2016: AstraZeneca announces 1st Quarter 2016 Results 86
Apr 29, 2016: AstraZeneca Announces Q1 2016 Results 97
Feb 04, 2016: Full-Year and Q4 2015 Results 99
Feb 04, 2016: AstraZeneca Full-Year and Q4 2015 Results 101
Corporate Communications 114
Nov 09, 2016: Change To Astrazeneca Board Of Directors 114
Sep 28, 2016: Change To Astrazeneca Board Of Directors 115
Other Significant Developments 116
Sep 21, 2016: AstraZeneca Selects LLamasoft as Supply Chain Design Partner of Choice 116
Appendix 117
Methodology 117
About GlobalData 117
Contact Us 117
Disclaimer 117

List of Tables
AstraZeneca Plc, Medical Equipment, Key Facts, 2015 1
AstraZeneca Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
AstraZeneca Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
AstraZeneca Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 8
AstraZeneca Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
AstraZeneca Plc, Deals By Market, 2011 to YTD 2017 10
AstraZeneca Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
Definiens Raises USD20.3 Million in Venture Financing Round 14
CeraPedics Raises US$19 Million In Series C Financing 15
Definiens Raises US$13 Million In Venture Financing 16
Ambit Biosciences Secures US$30 Million In Series D-2 Financing 17
AstraZeneca Enters into Agreement with Genedata 19
Neoprobe Enters Into Licensing Agreement With AstraZeneca 20
AgPlus Diagnostics Enters into Agreement with AstraZeneca 21
Indivumed Partners with Definiens 22
Foundation Medicine Enters into Agreement with AstraZeneca 23
MedImmune Enters into Agreement with Genisphere 23
Definiens Partners with MolecularMD 24
Human Longevity Partners with AstraZeneca 25
PROOF Centre Partners with AstraZeneca 26
Labcyte Enters into Agreement with AstraZeneca 26
HighRes Biosolutions Enters into Agreement with AstraZeneca 27
AstraZeneca Enters into Research Agreement with Sutter Health 28
Myriad Genetics Expands Agreement with AstraZeneca 29
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 30
AstraZeneca Enters into Co-Development Agreement with Qiagen 31
AstraZeneca Enters into Co-Development Agreement with Roche 32
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 32
Ventana Medical Enters into Co-Development Agreement with MedImmune 33
Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test 34
Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 35
Oxford Cancer Biomarkers Enters Into Agreement With AstraZeneca For Biomarker Discovery 36
AstraZeneca Enters Into Research Agreement With Karolinska Institutet 36
Metamark Genetics Enters Into Co-Development Agreement With Definiens 37
Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement 38
Leica Microsystems Enters Into Co-Marketing Agreement With Definiens 39
Definiens Enters Into An Agreement With Cernostics 40
Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens 41
AstraZeneca Rumored To Merge With Amgen 42
AstraZeneca Prices Private Placement of 0.875% Notes Due 2021 43
Pfizer May Increase Bid to Acquire AstraZeneca 43
MedImmune Acquires Definiens for USD150 Million 45
AstraZeneca Rumored To Acquire Forest Labs For US$15 Billion 46
Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company 47
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 48
DENTSPLY International Acquires Astra Tech From AstraZeneca For US$1,800 Million 49
AstraZeneca Plc, Key Competitors 52
AstraZeneca Plc, Key Employees 53
AstraZeneca Plc, Subsidiaries 55

List of Figures
AstraZeneca Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
AstraZeneca Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
AstraZeneca Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
AstraZeneca Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
AstraZeneca Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
AstraZeneca Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 8
AstraZeneca Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
AstraZeneca Plc, Medical Equipment, Deals by Market, 2011 to YTD 2017 10

★海外企業調査レポート[AstraZeneca Plc (AZN):企業のM&A・提携動向(医療機器分野)]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • FUJIFILM Holdings Corporation:企業の戦略・SWOT・財務情報
    FUJIFILM Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary FUJIFILM Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Takara Bio Inc (4974)-医療機器分野:企業M&A・提携分析
    Summary Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments. The company sells gene amplification system and offers scientific instruments. Takara also provides contract res …
  • Crescita Therapeutics Inc (CTX):企業財務及び戦略的SWOT分析
    Summary Crescita Therapeutics Inc (Crescita Therapeutics) develops products for the treatment of skin diseases and their symptoms. The company’s product portfolio includes over-the-counter and prescription products such as topical creams. It offers pliaglis, a local anesthetic cream for superficial …
  • Associated British Foods plc:企業の戦略・SWOT・財務分析
    Associated British Foods plc - Strategy, SWOT and Corporate Finance Report Summary Associated British Foods plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Lighting Science Group Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Lighting Science Group Corporat …
  • Sillajen Biotherapeutics (215600):製薬・医療:M&Aディール及び事業提携情報
    Summary Sillajen Biotherapeutics (SillaJen), formerly SillaJen Inc, is a biotechnology company that designs and develops oncolytic immunotherapeutics for the treatment of cancer. The company’s pipeline products comprise Pexa-Vec, an oncolytic immunotherapeutic virus which is in Phase III trial that …
  • Pro-Dex, Inc. (PDEX):企業財務及び戦略的SWOT分析
    Summary Pro-Dex, Inc. (Pro-Dex) is a medical device company that designs, develops, manufactures and markets powered surgical devices. The company’s products solutions include motion control, finished medical devices, plastic injection molding, micro air-motors, dental products, and torque wrenches. …
  • Amita Technologies Inc. (5233):企業の財務及び戦略的SWOT分析
    Summary Amita Technologies Inc. (Amita Tech) is a battery manufacturer that designs and manufactures Lithium-Ion Polymer battery packs and related products. The company offers products that include energy storage system, cell, hard pack, camcorder-AN series, camcorder-BP series, E bank, and accessor …
  • Biotecnol, Inc.(製薬・医療分野):企業M&A動向
    Summary Biotecnol, Inc. (Biotecnol) is a biotechnology company. The company develops antibody-based therapeutics for the treatment of diseases in a wide range of therapeutic areas and indications. It develops therapeutics based on its proprietary tribody technology. The company’s pipeline includes t …
  • Kommunal Landspensjonskasse gjensidig forsikringsselskap:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Kommunal Landspensjonskasse gje …
  • Neurosigma Inc:企業の製品パイプライン分析2018
    Summary Neurosigma Inc (Neurosigma) is a life science company that develops and commercializes trigeminal nerve stimulation technologies for neurologic and psychiatric disorders. The company offers treatments for epilepsy, depression, attention deficit hyperactivity disorder, and post-traumatic stre …
  • Flagstar Bancorp, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Flagstar Bancorp, Inc. Mergers …
  • Pacific Edge Limited (PEB):企業の財務及び戦略的SWOT分析
    Summary Pacific Edge Limited (PEB) is a medical diagnostics company that discovers and commercializes diagnostic and prognostic technology for the early detection and monitoring of cancer. The company identifies gene and protein signatures for the development of cancer management tools. Its cxbladde …
  • S Net Systems Inc. (038680):企業の財務及び戦略的SWOT分析
    Summary S Net Systems Inc. (S Net Systems) is an information technology company that offers products such as real time location systems (RTLSs) and Meta provisioning systems (MePSs). The company provides network integration services, network equipment, security solutions, voice over internet protoco …
  • Datalinks Corporation (2145):企業の財務及び戦略的SWOT分析
    Summary Datalinks Corporation (Datalinks) a subsidiary of DTS Corporation is an information technology company that offers system solutions. The company designs, installs and provides technical support for information storage infrastructures. It offers services such as advanced services, architectur …
  • Biovest International, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Biovest International, Inc. Mer …
  • Detroit Medical Center:企業の戦略的SWOT分析
    Detroit Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Galp Energia SGPS SA (GALP):石油・ガス:M&Aディール及び事業提携情報
    Summary Galp Energia SGPS SA (Galp) is an integrated energy company. It explores for, develops and produces crude oil and natural gas, refines crude oil, and markets refined petroleum products. The company also conducts power generation, produces biodiesel and trades gas. It imports, transports and …
  • Diversicare Healthcare Services, Inc. (DVCR):企業概要、財務及び戦略的SWOT分析
    Summary Diversicare Healthcare Services, Inc. (Diversicare) is a healthcare service provider. The company provides long-term care services to nursing home patients. It offers services such as short term rehabilitation, hospice care, lighthouse memory care, life steps rehabilitation program, complex …
  • Synnex (Thailand) Public Company Limited (SYNEX):企業概要、財務及び戦略的SWOT分析
    Summary Synnex (Thailand) Public Company Limited (Synnex) is an information technology service provider. The company distributes IT products to retailers and wholesalers worldwide. Its products include CPU, data storage media, digital camera, display card, fax and supplies, harddisk, headset, inkjet …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆